回应上周’s 信件 美国商务部解释了他们与《专利改革法》的协议和分歧，高级医疗技术协会的总顾问克里斯托弗·怀特（Christopher White）发表声明，对拒绝接受第4条表示赞赏。
//www.bcaiwa.com"AdvaMed applauds the Department of Commerce’s continued support for a strong patent system, which allows America’s medical technology industries to innovate tomorrow’s life-saving, life-enhancing treatments." White continued, speaking out against the language in the 专利改革法, which he (and many others) believe would "reduce the incentive to innovate" and "may actually encourage patent infringement."
//www.bcaiwa.comIn describing the importance of the role of innovating in the medical field, White described the medical technology industry as a "highly innovative" one that "brings tremendous value to patients through short life-cycles and rapidly improving technology." He further explained that even tiny innovations can "significantly advance the safety and effectiveness" of a particular medical device.
//www.bcaiwa.comAs a 医学专利律师, I’ve seen the difference small improvements to medical technology and devices can make. Moreover, as an ardent supporter of continual innovation, I, too, am relieved that the patent system will retain its integrity and strength.